Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 976 AL 990

Quantitative Timed-Up-and-Go Parameters in Relation to Cognitive Parameters and Health-Related Quality of Life in Mild-to-Moderate Parkinson's Disease

Van Uem JM, Walgaard S, Ainsworth E, Hasmann SE, Heger T, Nussbaum S, Hobert MA, Micó-Amigo EM, Van Lummel RC, Berg D, Maetzler W.

PLoS One. 2016 Apr 7;11(4):e0151997. doi: 10.1371/journal.pone.0151997. eCollection 2016.

[Influencing factors of visual hallucinations in patients with Parkinson's disease and its relationship with sleep disorders]

Wu DD, Li SH, Jin LY, Jin Y, Cui YY, Zhao H, Liu HJ, Ma XX, Su W, Chen HB.

Zhonghua Yi Xue Za Zhi. 2016 Apr 5;96(13):1016-20. doi: 10.3760/cma.j.issn.0376-2491.2016.13.007.

Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review

Desmarais P, Massoud F, Filion J, Nguyen QD, Bajsarowicz P.

J Geriatr Psychiatry Neurol. 2016 Jul;29(4):227-36. doi: 10.1177/0891988716640378. Epub 2016 Apr 6.

Risk of Parkinson's Disease Among Patients with Psoriasis: A Systematic Review and Meta-analysis

Ungprasert P, Srivali N, Kittanamongkolchai W.

Indian J Dermatol. 2016 Mar-Apr;61(2):152-6. doi: 10.4103/0019-5154.177771.

Quantification of the environmental neurotoxin annonacin in Rat brain by UPLC-MS/MS

Bonneau N, Schmitz-Afonso I, Brunelle A, Touboul D, Champy P.

Toxicon. 2016 Aug;118:129-33. doi: 10.1016/j.toxicon.2016.03.015. Epub 2016 Apr 4.

Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study

Drapier S, Eusebio A, Degos B, Vérin M, Durif F, Azulay JP, Viallet F, Rouaud T, Moreau C, Defebvre L, Fraix V, Tranchant C, Andre K, Courbon CB, Roze E, Devos D.

J Neurol. 2016 Jun;263(6):1111-9. doi: 10.1007/s00415-016-8106-3. Epub 2016 Apr 8.

Simultaneous bioanalysis of rasagiline and its major metabolites in human plasma by LC-MS/MS: Application to a clinical pharmacokinetic study

Wang T, Yang L, Hua J, Xie H, Jiang X, Wang L.

J Pharm Biomed Anal. 2016 Jun 5;125:280-5. doi: 10.1016/j.jpba.2016.04.003. Epub 2016 Apr 1.

Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies

Takemoto M, Sato K, Hatanaka N, Yamashita T, Ohta Y, Hishikawa N, Abe K.

J Alzheimers Dis. 2016;52(1):205-11. doi: 10.3233/JAD-150952.

Validation of a Smartphone Application Measuring Motor Function in Parkinson's Disease

Lee W, Evans A, Williams DR.

J Parkinsons Dis. 2016 Apr 2;6(2):371-82. doi: 10.3233/JPD-150708.

Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx)

Fleisher JE, Dahodwala NA, Xie SX, Mayo M, Weintraub D, Chodosh J, Shea JA.

J Parkinsons Dis. 2016 Apr 2;6(2):383-92. doi: 10.3233/JPD-150765.

Outlining the psychopathology behind a case of conversion syndrome: Is a holistic approach beneficial?

Aquilina FF, Fondacaro DV.

Psych J. 2016 Mar;5(1):31-5. doi: 10.1002/pchj.125.

Psychological Predictors of Anxiety and Depression in Parkinson's Disease: A Systematic Review

Garlovsky JK, Overton PG, Simpson J.

J Clin Psychol. 2016 Oct;72(10):979-98. doi: 10.1002/jclp.22308. Epub 2016 Apr 8.

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease

Renoux C, Dell'Aniello S, Khairy P, Marras C, Bugden S, Turin TC, Blais L, Tamim H, Evans C, Steele R, Dormuth C, Ernst P; Canadian Network for Observational Drug Effect Studies (CNODES) investigators.

Br J Clin Pharmacol. 2016 Aug;82(2):461-72. doi: 10.1111/bcp.12964. Epub 2016 May 19.

Quantifying rigidity of Parkinson's disease in relation to laxative treatment: a service evaluation

Augustin AD, Charlett A, Weller C, Dobbs SM, Taylor D, Bjarnason I, Dobbs RJ.

Br J Clin Pharmacol. 2016 Aug;82(2):441-50. doi: 10.1111/bcp.12967. Epub 2016 May 21.

Controlled pilot study of the effects of power yoga in Parkinson's disease

Ni M, Mooney K, Signorile JF.

Complement Ther Med. 2016 Apr;25:126-31. doi: 10.1016/j.ctim.2016.01.007. Epub 2016 Feb 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias